News

A new research unit which specialises in early HTA, Medical Innovation Development and Assessment Support (MIDAS), was also established to support and advance medical innovation development by fostering interdisciplinary collaboration, identifying promising medical technologies, promoting cutting-edge research, facilitating translational efforts, and demonstrating the economic value of early-stage medical innovations. The operation of MIDAS will be supported by HITAP and the School.

Prof Hsu has made significant impact in his research especially in the areas of surveillance and control of antimicrobial resistant (AMR). His impressive research has earned him the reputation as the “go to person” in infectious disease clinical practice and research in NUS and Singapore. He is currently the first Vice Dean of Global Health in SSHSPH and leads the Global Health Office to support SSHSPH’s regional and global health education and research work.

The 2023 Agenda for Sustainable Development is transformative. It is a plan of action for the people, planet and prosperity. The health of people is central to all the Sustainable Development Goals (SDGs) but these are encountering major challenges and roadblocks because of the recent pandemic, crowded global health infrastructure, poor health governance, inertia and inaction by governments and partners, with people around the world confronted with the prospect of health inequities and continued systemic poverty.

On the 26th of May 2023, the National Cohorts Office had the privilege of hosting a seminar featuring four established guest speakers, namely, Dr Joe McNamara, Head of Cohort Strategy, Medical Research Council, UK, Professor Per Hall, Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Sweden, Professor Andrew Morris, Director, Health Data Research UK and Ms Koh Mingshi, Director, Chief Health Scientist Office, Ministry of Health, Singapore.

Join expert Thai policymakers & stakeholders for a discussion on the successes of strategic health purchasing for UHC in Thailand. This webinar is organised in collaboration with Thammasat University Faculty of Economics (Bangkok).

On 11 April 2023, the research team led by Alvin Chua, Pami Shrestha and Helena Legido-Quigley, together with the Asia Pacific Observatory on Health Systems and Policies (APO) conducted a workshop/policy dialogue to discuss the development and implementation of the national action plan (NAP) on antimicrobial resistance (AMR) in a selection of Asian countries. The event provided an opportunity for participants to share and discuss (1) research findings from the individual country analyses of the NAPs, (2) lessons learnt and best practices in AMR management, (3) AMR research priorities, and (4) how to keep AMR in the political agenda.

In a generous act of philanthropy, the TL Whang Foundation has graciously donated a gift to the School to enable deserving students to further their academic pursuits in public health. The prestigious TL Whang Foundation Master of Public Health Scholarship covers tuition fees and a monthly stipend for full-time candidates who are citizens of Thailand and Vietnam, in particular candidates who demonstrate potential for community impact. TL Whang Foundation’s directors, Mr Whang Shang Ying and Ms Chan Chia Lin, visited the School on 5 May 2023 and were warmly receivedRead more

Author: Ryan Rachmad Nugraha, Doctoral Researcher at Center for Population, Family and Health, University of Antwerp Strategic Purchasing (SP) in healthcare refers to a purchasing system that efficiently addresses ‘what’ to buy, ‘how’ to buy, and ‘from whom’ to buy to achieve the best possible health outcomes. This can include the purchasing of healthcare services, equipment, medicines, healthcare support services, and more. Through strategic purchasing, countries can allocate their resources for healthcare efficiently, particularly when facing constraints. This includes Indonesia, a country with a huge population yet limited healthcare resources.Read more

A Memorandum of Understanding (MOU) has been signed between NUS Saw Swee Hock School of Public Health (NUS SSHSPH) and Tsinghua University Vanke School of Public Health (Tsinghua VSPH) focusing on expanding collaboration between the two institutions to promote joint research and development activities. The signing ceremony took place on 29 April 2023, during a visit by a delegation from NUS SSHSPH to Tsinghua VSPH in Beijing, China. Prof Margaret Chan, Founding Dean of Tsinghua VSPH, and Prof Teo Yik Ying, Dean of NUS SSHSPH, signed the MOU on behalfRead more

Join us for the next instalment of the ‘Women in Global Health’ webinar series, as Professor Marcia Inhorn (Yale University) shares her latest research on egg freezing. Prof Inhorn’s findings highlight the role of Medical Anthropology in global health and shed light on how technology, race and religion influence assisted reproduction. Date & time: 19 April 2023, 9am SGT

The Ministry of Health introduced a Cancer Drug List (CDL) of clinically proven and more cost-effective cancer treatments in Sep 2022. This came after a major review of MediShield Life which found that Singapore’s expenditure on cancer drugs grew by 20 per cent annually from 2016 to 2019. All Integrated Shield Plans (IPs) from private insurers that are purchased or renewed from Apr 1 will only cover treatments on an approved cancer drug list. How will the new policy affect patients undergoing treatment? In the long run, can this beRead more